Global Oral COVID-19 Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Page: 91
Published Date: 29 Jul 2023
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Oral COVID-19 Vaccine market size was valued at USD 866.4 million in 2022 and is forecast to a readjusted size of USD 1224.9 million by 2029 with a CAGR of 5.1% during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Oral COVID-19 Vaccine industry chain, the market status of Adults (Tablet Type, Inhalable Type), Children (Tablet Type, Inhalable Type), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Oral COVID-19 Vaccine.
Regionally, the report analyzes the Oral COVID-19 Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Oral COVID-19 Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Oral COVID-19 Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Oral COVID-19 Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tablet Type, Inhalable Type).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Oral COVID-19 Vaccine market.
Regional Analysis: The report involves examining the Oral COVID-19 Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Oral COVID-19 Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Oral COVID-19 Vaccine:
Company Analysis: Report covers individual Oral COVID-19 Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Oral COVID-19 Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Adults, Children).
Technology Analysis: Report covers specific technologies relevant to Oral COVID-19 Vaccine. It assesses the current state, advancements, and potential future developments in Oral COVID-19 Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Oral COVID-19 Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Oral COVID-19 Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Tablet Type
Inhalable Type
Market segment by Application
Adults
Children
Elderly
Major players covered
Pfizer
CanSino Biologics
Kindred Biosciences, Inc.
Zhejiang Huahai Pharmaceutical Co.,ltd.
Shandong Xinhua Pharmaceutical
Kintor Pharmaceutical
Henan Genuine Biotech Co., Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Oral COVID-19 Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oral COVID-19 Vaccine, with price, sales, revenue and global market share of Oral COVID-19 Vaccine from 2018 to 2023.
Chapter 3, the Oral COVID-19 Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oral COVID-19 Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oral COVID-19 Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oral COVID-19 Vaccine.
Chapter 14 and 15, to describe Oral COVID-19 Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Oral COVID-19 Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oral COVID-19 Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Tablet Type
1.3.3 Inhalable Type
1.4 Market Analysis by Application
1.4.1 Overview: Global Oral COVID-19 Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Adults
1.4.3 Children
1.4.4 Elderly
1.5 Global Oral COVID-19 Vaccine Market Size & Forecast
1.5.1 Global Oral COVID-19 Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oral COVID-19 Vaccine Sales Quantity (2018-2029)
1.5.3 Global Oral COVID-19 Vaccine Average Price (2018-2029)
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Oral COVID-19 Vaccine Product and Services
2.1.4 Pfizer Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 CanSino Biologics
2.2.1 CanSino Biologics Details
2.2.2 CanSino Biologics Major Business
2.2.3 CanSino Biologics Oral COVID-19 Vaccine Product and Services
2.2.4 CanSino Biologics Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 CanSino Biologics Recent Developments/Updates
2.3 Kindred Biosciences, Inc.
2.3.1 Kindred Biosciences, Inc. Details
2.3.2 Kindred Biosciences, Inc. Major Business
2.3.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product and Services
2.3.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Kindred Biosciences, Inc. Recent Developments/Updates
2.4 Zhejiang Huahai Pharmaceutical Co.,ltd.
2.4.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Details
2.4.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Major Business
2.4.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product and Services
2.4.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments/Updates
2.5 Shandong Xinhua Pharmaceutical
2.5.1 Shandong Xinhua Pharmaceutical Details
2.5.2 Shandong Xinhua Pharmaceutical Major Business
2.5.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product and Services
2.5.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Shandong Xinhua Pharmaceutical Recent Developments/Updates
2.6 Kintor Pharmaceutical
2.6.1 Kintor Pharmaceutical Details
2.6.2 Kintor Pharmaceutical Major Business
2.6.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Product and Services
2.6.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Kintor Pharmaceutical Recent Developments/Updates
2.7 Henan Genuine Biotech Co., Ltd.
2.7.1 Henan Genuine Biotech Co., Ltd. Details
2.7.2 Henan Genuine Biotech Co., Ltd. Major Business
2.7.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product and Services
2.7.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Henan Genuine Biotech Co., Ltd. Recent Developments/Updates
3.1 Global Oral COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oral COVID-19 Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Oral COVID-19 Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oral COVID-19 Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oral COVID-19 Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Oral COVID-19 Vaccine Manufacturer Market Share in 2022
3.5 Oral COVID-19 Vaccine Market: Overall Company Footprint Analysis
3.5.1 Oral COVID-19 Vaccine Market: Region Footprint
3.5.2 Oral COVID-19 Vaccine Market: Company Product Type Footprint
3.5.3 Oral COVID-19 Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Oral COVID-19 Vaccine Market Size by Region
4.1.1 Global Oral COVID-19 Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Oral COVID-19 Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Oral COVID-19 Vaccine Average Price by Region (2018-2029)
4.2 North America Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.3 Europe Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.5 South America Oral COVID-19 Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Oral COVID-19 Vaccine Consumption Value (2018-2029)
5.1 Global Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Oral COVID-19 Vaccine Consumption Value by Type (2018-2029)
5.3 Global Oral COVID-19 Vaccine Average Price by Type (2018-2029)
6.1 Global Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Oral COVID-19 Vaccine Consumption Value by Application (2018-2029)
6.3 Global Oral COVID-19 Vaccine Average Price by Application (2018-2029)
7.1 North America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Oral COVID-19 Vaccine Market Size by Country
7.3.1 North America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8.1 Europe Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Oral COVID-19 Vaccine Market Size by Country
8.3.1 Europe Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9.1 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oral COVID-19 Vaccine Market Size by Region
9.3.1 Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10.1 South America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Oral COVID-19 Vaccine Market Size by Country
10.3.1 South America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11.1 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oral COVID-19 Vaccine Market Size by Country
11.3.1 Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12.1 Oral COVID-19 Vaccine Market Drivers
12.2 Oral COVID-19 Vaccine Market Restraints
12.3 Oral COVID-19 Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13.1 Raw Material of Oral COVID-19 Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oral COVID-19 Vaccine
13.3 Oral COVID-19 Vaccine Production Process
13.4 Oral COVID-19 Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oral COVID-19 Vaccine Typical Distributors
14.3 Oral COVID-19 Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Oral COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oral COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Oral COVID-19 Vaccine Product and Services
Table 6. Pfizer Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. CanSino Biologics Basic Information, Manufacturing Base and Competitors
Table 9. CanSino Biologics Major Business
Table 10. CanSino Biologics Oral COVID-19 Vaccine Product and Services
Table 11. CanSino Biologics Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. CanSino Biologics Recent Developments/Updates
Table 13. Kindred Biosciences, Inc. Basic Information, Manufacturing Base and Competitors
Table 14. Kindred Biosciences, Inc. Major Business
Table 15. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product and Services
Table 16. Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Kindred Biosciences, Inc. Recent Developments/Updates
Table 18. Zhejiang Huahai Pharmaceutical Co.,ltd. Basic Information, Manufacturing Base and Competitors
Table 19. Zhejiang Huahai Pharmaceutical Co.,ltd. Major Business
Table 20. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product and Services
Table 21. Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments/Updates
Table 23. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Shandong Xinhua Pharmaceutical Major Business
Table 25. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product and Services
Table 26. Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Shandong Xinhua Pharmaceutical Recent Developments/Updates
Table 28. Kintor Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Kintor Pharmaceutical Major Business
Table 30. Kintor Pharmaceutical Oral COVID-19 Vaccine Product and Services
Table 31. Kintor Pharmaceutical Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Kintor Pharmaceutical Recent Developments/Updates
Table 33. Henan Genuine Biotech Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 34. Henan Genuine Biotech Co., Ltd. Major Business
Table 35. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product and Services
Table 36. Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Henan Genuine Biotech Co., Ltd. Recent Developments/Updates
Table 38. Global Oral COVID-19 Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 39. Global Oral COVID-19 Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 40. Global Oral COVID-19 Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 41. Market Position of Manufacturers in Oral COVID-19 Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 42. Head Office and Oral COVID-19 Vaccine Production Site of Key Manufacturer
Table 43. Oral COVID-19 Vaccine Market: Company Product Type Footprint
Table 44. Oral COVID-19 Vaccine Market: Company Product Application Footprint
Table 45. Oral COVID-19 Vaccine New Market Entrants and Barriers to Market Entry
Table 46. Oral COVID-19 Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 47. Global Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 48. Global Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 49. Global Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 50. Global Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 51. Global Oral COVID-19 Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 52. Global Oral COVID-19 Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 53. Global Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 54. Global Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 55. Global Oral COVID-19 Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 56. Global Oral COVID-19 Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 57. Global Oral COVID-19 Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 58. Global Oral COVID-19 Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 59. Global Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 60. Global Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 61. Global Oral COVID-19 Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 62. Global Oral COVID-19 Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 63. Global Oral COVID-19 Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 64. Global Oral COVID-19 Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 65. North America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 66. North America Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 67. North America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 68. North America Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 69. North America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 70. North America Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 71. North America Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 72. North America Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 73. Europe Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 74. Europe Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 75. Europe Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 76. Europe Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 77. Europe Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 78. Europe Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 79. Europe Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 82. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 83. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 84. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 85. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 86. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 87. Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 88. Asia-Pacific Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 89. South America Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 90. South America Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 91. South America Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 92. South America Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 93. South America Oral COVID-19 Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 94. South America Oral COVID-19 Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 95. South America Oral COVID-19 Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 96. South America Oral COVID-19 Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 97. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 98. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 99. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 100. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 101. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 102. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 103. Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 104. Middle East & Africa Oral COVID-19 Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 105. Oral COVID-19 Vaccine Raw Material
Table 106. Key Manufacturers of Oral COVID-19 Vaccine Raw Materials
Table 107. Oral COVID-19 Vaccine Typical Distributors
Table 108. Oral COVID-19 Vaccine Typical Customers
List of Figures
Figure 1. Oral COVID-19 Vaccine Picture
Figure 2. Global Oral COVID-19 Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oral COVID-19 Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Tablet Type Examples
Figure 5. Inhalable Type Examples
Figure 6. Global Oral COVID-19 Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oral COVID-19 Vaccine Consumption Value Market Share by Application in 2022
Figure 8. Adults Examples
Figure 9. Children Examples
Figure 10. Elderly Examples
Figure 11. Global Oral COVID-19 Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Oral COVID-19 Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Oral COVID-19 Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Oral COVID-19 Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Oral COVID-19 Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Oral COVID-19 Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Oral COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Oral COVID-19 Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Oral COVID-19 Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Oral COVID-19 Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Oral COVID-19 Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Oral COVID-19 Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Oral COVID-19 Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Oral COVID-19 Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Oral COVID-19 Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Oral COVID-19 Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Oral COVID-19 Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Oral COVID-19 Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Oral COVID-19 Vaccine Market Drivers
Figure 74. Oral COVID-19 Vaccine Market Restraints
Figure 75. Oral COVID-19 Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Oral COVID-19 Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Oral COVID-19 Vaccine
Figure 79. Oral COVID-19 Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Pfizer CanSino Biologics Kindred Biosciences, Inc. Zhejiang Huahai Pharmaceutical Co.,ltd. Shandong Xinhua Pharmaceutical Kintor Pharmaceutical Henan Genuine Biotech Co., Ltd.
Related Reports
29 Jul 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
